Clinical trialNo phase (not a drug trial)Active not recruiting
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)
- Outcome
- Ongoing
- Phase
- No phase (not a drug trial)
- Status
- Active not recruiting
- Study type
- Interventional
- Start
- 20 September 2021
- Expected end
- 20 September 2027
- Enrollment
- 324 participants
- Sites
- 7
- Primary outcomes
- Average Fatigue Severity from the Brief Fatigue Inventory (BFI)
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 20 October 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The overarching long-term goal of the Integrative Medicine for Patient-reported Outcomes Values and Experience (IMPROVE) research program is to evaluate whether integrating a virtual mind-body programming, Integrative Medicine at Home (IM@Home), will improve patient perceived values, outcomes, and experiences as they undergo systemic cancer treatment such as chemotherapy, immunotherapy, radiotherapy, targeted agents, cytoreductive surgery.
Papers 2
- Builds on itBenefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study o… DOI 10.2196/80075↗
- Builds on itRandomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatm… DOI 10.1038/s41746-024-01387-z↗